Minute Insight: Medtronic Counters Abbott With New Micra Leadless Pacemakers
About a month after it approved Abbott’s Aveir VR leadless pacemaker, the FDA approved two new models of Medtronic’s Micra leadless pacemaker.
You may also be interested in...
Minute Insight: Medtronic’s Extravascular ICD Earns European Approval
The Aurora extravascular implantable cardioverter defibrillator and the Epsila extravascular lead earned a CE mark supported by results from a global pivotal study.
Minute Insight: Abbott’s Aveir VR To Take On Medtronic’s Micra In US Leadless Pacemaker Market
The US FDA approved Aveir VR to treat significant bradycardia on 4 April. It is the world’s only leadless pacemaker with Abbott’s proprietary mapping capability that helps physicians correctly position the device inside the right ventricle.
HRS 2020: New Trial Data Support Medtronic’s Micra Pacemaker
The Micra CED study showed a lower rate of complications with the Micra leadless pacemaker than transvenous single-chamber pacemakers.